EMA Guide To Help Regulators Assess Subgroup Analyses In Confirmatory Trials
A new final guidance by the European Medicines Agency outlines broad principles and strategies that regulatory assessors can use when investigating subgroups in confirmatory clinical trials.
You may also be interested in...
The European Medicines Agency has identified key areas where stakeholders want to see it deliver a real change over the next five years.
Singapore is taking steps to align good manufacturing practice requirements for chemical and biologic drug substance manufacturers and has rolled out a one-year transition plan for compliance.
Users of the new catalogs will benefit from a modern technology with enhanced view, search, export and data submission functionalities, says the European Commission.